Skip to main content
SpringerLink
Log in

Antibacterials/antivirals

Off-label use in COVID-19 pneumonia, and induction of resistance through mutation selection: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Gomis-Font MA, et al. Emergence of Resistance to Novel Cephalosporin-beta-Lactamase Inhibitor Combinations through the Modification of the Pseudomonas aeruginosa MexCD-OprJ Efflux Pump. Antimicrobial Agents and Chemotherapy 65: 1-5, No. 8, Aug 2021. Available from: URL: http://doi.org/10.1128/AAC.00089-21

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antibacterials/antivirals. Reactions Weekly 1876, 41 (2021). https://doi.org/10.1007/s40278-021-03290-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-03290-0

Search

Navigation